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INTRODUCTION
Neonatal encephalopathy occurs in 1-6 per 1000 live term births and is an important cause of mortality and long-term neurological disabilities, including cerebral palsy and cognitive impairment. [1] Current interventions are limited, including therapeutic hypothermia [2] [3] [4] [5] .
Therefore, avoiding secondary injury by maintaining homeostasis with attention to glucose, cardio-respiratory status and oxygenation is critical. [6] Although hypoxia-ischemia has been the major focus of research on neonatal encephalopathy, etiologies can be varied, including hypoglycemia and other metabolic derangements.
Independent of hypoxia-ischemia, hypoglycemia is a common problem in newborns.
Neonatal hypoglycemia has been associated with adverse outcome in term infants, resulting in visual impairment, [7] localization-related epilepsy, [8] [9] [10] and cognitive deficits. [11] [12] [13] Animal and human research suggest that the combination of perinatal hypoxia-ischemia and neonatal hypoglycemia may result in worsened outcomes. In animal models, a higher risk of mortality and seizures has been reported when hypoglycemia occurs in the context of hypoxia-ischemia. [14, 15] In a case-control study of 60 neonatal encephalopathy cases and 60 term controls, there were significantly lower glucose levels in the cases, and significant linear correlation between glucose level and severity of encephalopathy. [16] In a cohort of 52 term infants with encephalopathy, glucose <46 mg/dL in the first 6 hours of life was associated with severe encephalopathy and adverse outcome at 2 years. [17] Brain imaging in neonatal hypoglycemia is used to assess injury, and a correlation between hypoglycemia and parieto-occipital injury in isolated neonatal hypoglycemia has been identified. [7, 18, 19] However, no studies have systematically examined the patterns of brain injury associated with hypoglycemia in the context of neonatal encephalopathy. This study 4 reports the relationship between early neonatal hypoglycemia, brain injury assessed by MRI, and neurodevelopmental outcome in a prospective cohort of term newborns at risk for encephalopathy.
METHODS

Study subjects
Term neonates born between 1994 and 2010 at the University of California San Francisco (UCSF) with at risk for neonatal encephalopathy or a marker of perinatal depression were included in this prospective cohort study. Markers include an umbilical artery pH <7.1, umbilical artery base deficit >10, or a 5-minute Apgar score ≤5. Newborns were excluded if their gestational age at birth was <36 weeks or there were suspected or confirmed congenital malformations, inborn errors of metabolism, or congenital infections based on clinical examinations and laboratory studies. Clinical data, including maternal, perinatal, and early postnatal history, was collected prospectively from patient charts. Neonatal hypoglycemia was defined as any clinical measurement of glucose <46 mg/dL within the first 24 hours of life. [17] An encephalopathy score, assessing mental status, ability to feed, need for respiratory support, tone, reflexes, and the presence of seizures was scored for the first 24 hours of life. [20] Parental consent was obtained for all cases following a protocol approved by the Committee on Human Research at UCSF.
MRI studies
Neonates were transported to the MRI scanner in a custom MR-compatible incubator with specialized neonatal head coils to provide a quiet, well-monitored environment for the neonate, 
Statistical analysis
Statistical analysis was performed using Stata 11 (Stata Corporation, College Station, TX).
Descriptive statistics were used to compare clinical features of subjects with and without hypoglycemia in the first 24 hours of life. Due to possible confounding of the degree of perinatal hypoxia-ischemia on the association between hypoglycemia and outcome, regression analyses were performed adjusting for all available measures of severity of perinatal hypoxia-ischemia, including uterine artery pH, respiratory support (continuous positive airway pressure (CPAP) or intubation), cardiac massage, and 5-minute Apgar score. Adjustments were not made for 24-hour encephalopathy score or neonatal seizures, as these measures occur after and can be a result of neonatal hypoglycemia. [1] Logistic regression analysis was used to assess the association between neonatal hypoglycemia and regional brain injury. Ordinal logistic regression analysis was used to assess the association between neonatal hypoglycemia and neuromotor score. Linear regression analysis was used to assess the association between neonatal hypoglycemia and BSID mental developmental index (MDI) score. Due to possible differences in the BSID editions, primary analysis was performed using only those subjects tested with the BSID-2. Secondary analysis considered a mean of the cognitive and language scores on the BSID-3 to be equivalent to the MDI score of the BSID-2, in order to consider all subjects. [22] 7
RESULTS
Study subjects
A total of 94 subjects matched our study criteria and were enrolled during the period of 1994 to 2010. Hypoglycemia was detected in the first 24 hours of life in 15 of the 94 subjects (16%). The clinical demographics of this cohort are described in Table 1 
Brain injury patterns on MRI
Of the 94 subjects enrolled, 90 subjects had adequate brain MRI studies available for interpretation. Only one subject displayed the pattern of pericalcarine injury sometimes described with neonatal hypoglycemia, however no hypoglycemia was detected from clinical monitoring between birth and time of imaging.
Univariate logistic regression analyses were used to analyze the association between hypoglycemia in the first 24 hours of life and brain injury patterns on MRI. Results are summarized in Table 2 . The only brain region found to be significantly associated with hypoglycemia was injury in the corticospinal tract. Multivariate logistic regression analysis adjusting for markers of perinatal hypoxia-ischemia resulted in a continued significant 8 association between neonatal hypoglycemia and increased corticospinal tract injury (odds ratio 3.72, 95% CI 1.02 -13.57, P=0.047).
Neurodevelopmental outcome
Out of the cohort of 94 subjects, one-year outcomes were available in 73 subjects. One subject died in the perinatal period, having experienced neonatal hypoglycemia (lowest glucose level was 17 mg/dL), seizures, and depressed neurological status. Thus, outcome data were available for 79% of this cohort.
Multivariate ordinal logistic regression analysis was used to study the association between hypoglycemia and motor outcome. The mean neuromotor score was 1±1 for subjects without and 2±2 for those with neonatal hypoglycemia. In univariate analysis, there was a trend towards association between hypoglycemia and worsening of the neuromotor score (odds ratio 1.05, 95% CI -0.16 -2.25, P=0.089). Adjusting for markers of perinatal hypoxia-ischemia, hypoglycemia in the first 24 hours of life was associated with a 1.57 times increased odds for a one point worsening of the neuromotor score at one year of age (95% CI 0.085 -3.06, P=0.038).
There were an inadequate number of subjects with therapeutic hypothermia to assess the associations to motor outcome in this cohort.
A change in protocol to test subjects using a newer version of the BSID test in 2007 complicated the analysis of cognitive outcome. Considering only the subjects tested with the BSID-2 before 2007, the mean MDI score at 1 year was 92±13 for those without and 80±20 for those with neonatal hypoglycemia. Linear regression analysis was used to assess the association between hypoglycemia in the first 24 hours and cognitive outcome. In univariate analysis, hypoglycemia in the first 24 hours of life was associated with 12-point lower MDI scores at one year of age (95% CI -23 --1, P=0.027). Adjusting for markers of perinatal hypoxia-ischemia, hypoglycemia was associated with 15-point lower MDI scores (95% CI -26--3, P=0.015).
Further analysis was performed averaging the cognitive and language scores of the BSID-3 test to replace the MDI score. In univariate analysis, there is a trend towards an association between hypoglycemia and MDI scores (-8, 95% CI -17 -1, P=0.092). Again adjusting for potential confounders, hypoglycemia was associated with 12-point lower MDI scores (95% CI -23 --2, P=0.02). There were an inadequate number of subjects with therapeutic hypothermia to assess the associations to cognitive outcome in this cohort.
DISCUSSION
In this cohort study of MRI after neonatal encephalopathy, an independent association was found between hypoglycemia in the first 24 hours of life and increased risk of injury to the corticospinal tract. The classic parieto-occipital pattern of brain injury after isolated neonatal hypoglycemia was not observed in this setting. In addition, associations were found between hypoglycemia in the first 24 hours of life and motor and cognitive impairment at one-year follow-up.
Recent literature has suggested a specific pattern of brain injury and long-term deficits after isolated neonatal hypoglycemia. The first description of brain injury after neonatal hypoglycemia was by Spar et al. in 1994 , who reported a case of a newborn with over 15 hours of hypoglycemia.
[23] An MRI of the child's brain at 19 days of age showed generalized thinning of the cerebral cortex, with a predominant pattern of injury in the parieto-occipital lobes. As this child had no other identified risk factors, the injury was attributed to hypoglycemia. Since then, other studies have confirmed this posterior-predominant pattern of brain injury, and additional involvement of the underlying white matter tracts, corpus callosum, and thalamus. [18, 19] In the first six days of life, diffusion-weighted imaging is the most sensitive for identification of this parieto-occipital brain injury [7] , while later imaging may show gliosis and volume loss in the affected brain regions. [9] In keeping with this pattern of injury, the long-term sequelae observed after isolated neonatal hypoglycemia have been described in a neurologic syndrome of cortical visual loss, occipital localization-related epilepsy, and psychomotor retardation. [9, 10, 24] Much more extensive literature exists regarding the pattern of brain injury and long-term outcome after perinatal hypoxia-ischemia. Two distinct patterns of brain injury have been described in term newborns. Prolonged mild to moderate hypotension has been associated with a pattern of injury that involves the watershed zones between the anterior and middle cerebral artery and between the middle and posterior cerebral artery territories. Acute severe hypotension has been associated with a pattern of brain injury that involves the basal ganglia, thalamus, brainstem, sensorimotor cortex, and corticospinal tracts. [1, 25, 26] The basal ganglia/thalamus pattern of injury has been associated with more severe neonatal signs including increased need for resuscitation and higher degree of encephalopathy, in addition to higher risks for adverse neurodevelopmental outcome at 30 months. [21, 27] Outcomes after perinatal hypoxia-ischemia include death in as many as 20% of affected infants and permanent impairments in motor and cognitive function in 25%. [28, 29] Animal models have suggested increased morbidity and mortality when perinatal hypoxia-ischemia is combined with hypoglycemia, as compared with normoglycemic hypoxiaischemia. Newborn rat pups subjected to anoxia who were normoglycemic were found to survive ten-times longer than those with hypoglycemia. [14] When neonatal seizures occurred, ATP store depletion was much more significant in conjunction with hypoglycemia. [15] However, the implications of neonatal hypoglycemia in encephalopathy have been difficult to separate in humans. Higher rates of hypoglycemia have been associated with more severe neonatal encephalopathy. [16] Hypoglycemia in the first six hours of life has also been found to be associated with worse two-year outcome after neonatal encephalopathy. [17] Although different injury patterns are associated with isolated hypoglycemia and perinatal hypoxia-ischemia, our results suggest that a combination of the two conditions results in a pattern of more severe perinatal hypoxia-ischemia in the sensorimotor cortex and corticospinal tracts. The pattern of parieto-occipital brain injury described in isolated neonatal hypoglycemia is not seen, suggesting that this pattern may be seen predominantly in newborns without concomitant hypoxia-ischemia.
Many obstacles exist to understand the effects of hypoglycemia and perinatal hypoxiaischemia on neonatal encephalopathy and long-term outcome. The first difficulty is our poor understanding of the degree and duration of hypoglycemia required to result in brain injury.
Studies to date have used a range of cut-off values, the most common being 46mg/dL, as used in this study. Secondly, few independent markers exist to quantify the degree of perinatal hypoxiaischemia. Often, the Sarnat and Sarnat method [30] to stage the progression of symptoms after perinatal hypoxia-ischemia has been used to inappropriately define the severity of hypoxiaischemia. No reliable and specific laboratory markers exist to date, and thus the degree of perinatal hypoxia-ischemia is equated with the degree of clinical encephalopathy in the first few days of life. Unfortunately, since hypoglycemia occurs early in life, these clinical signs can also be a marker of injury associated with excessively low glucose.
This current study uses earlier markers of neonatal distress, including 5-minute Apgar scores, uterine artery pH, and the degree of respiratory and cardiac resuscitation to measure the degree of perinatal hypoxia-ischemia. Adjusting for these factors, neonatal hypoglycemia remains significantly associated with brain injury and adverse outcome. These findings seem to contradict Nadeem et al., [17] who found no association of hypoglycemia and injury after adjusting for the clinical severity of neonatal encephalopathy as determined using clinical signs in the first few days of life. The current findings of worsened injury patterns of hypoxia-ischemia associated with hypoglycemia suggest that clinical severity of encephalopathy may not be specific to hypoxia-ischemia alone, but may be augmented by hypoglycemia. Encephalopathic newborns with hypoglycemia were also found to have higher degrees of encephalopathy in the This study demonstrates that hypoglycemia is associated with a higher risk of corticospinal tract injury and adverse motor and cognitive outcomes at 12 months of age in infants with neonatal encephalopathy. Longer-term follow-up will be helpful to determine if these findings persist on subsequent follow-up examinations. This study also highlights the importance of finding specific early markers for adverse outcomes in neonatal encephalopathy, in order to better determine the specific effects of hypoxia-ischemia and concomitant factors such as hypoglycemia on brain injury and outcome. 
